Status:
RECRUITING
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
COVID-19 Infection
Melanoma
Eligibility:
All Genders
Brief Summary
The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quali...
Detailed Description
PRIMARY OBJECTIVES: I. Assess experiences during the COVID-19 pandemic (e.g., exposure, risk factors, testing, isolation, seropositivity, hospitalization, loss of family or friends); COVID-19-specifi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients who have signed consent for PA15-0336
- Has an active email address and can be contacted via MyChart
- Documentation of being alive per the cancer registry
Exclusion
Key Trial Info
Start Date :
June 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
1152 Patients enrolled
Trial Details
Trial ID
NCT04474301
Start Date
June 11 2020
End Date
December 30 2026
Last Update
October 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030